Shanghai Mengke Pharmaceutical Co., Ltd. voluntarily disclosed an announcement regarding the results of Phase I clinical trials of MRX-8 in China.
Shanghai Mengke Pharmaceutical Co., Ltd. Investor Relations Event Schedule (May 9, 2024)
Shanghai Mengke Pharmaceutical Co., Ltd. Report for the first quarter of 2024
Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders of Shanghai Mengke Pharmaceutical Co., Ltd.
Legal Opinion of Shanghai Fangda Law Firm on the 2023 Annual General Meeting of Shareholders of Shanghai Mengke Pharmaceutical Co., Ltd.
Shanghai Mengke Pharmaceutical Co., Ltd. Investor Relations Event Schedule (April 17, 2024)
Announcement of Shanghai Mengke Pharmaceutical Co., Ltd. on the completion of the plan for shareholders, directors and senior management to increase their share holdings in the company
China International Finance Corporation\'s inspection opinion on the initial public offering of some restricted shares of Shanghai Mengke Pharmaceutical Co., Ltd. and the lifting of the listing and circulation ban
Announcement on the initial public offering of some restricted shares of Shanghai Mengke Pharmaceutical Co., Ltd.
Shanghai Mengke Pharmaceutical Co., Ltd. Investor Relations Event Schedule (April 9-10, 2024)
Announcement of Shanghai Mengke Pharmaceutical Co., Ltd. on attending the 2023 Pharmaceutical Special Group Briefing
Announcement of Shanghai Mengke Pharmaceutical Co., Ltd. on the progress of shareholders, directors and senior management to increase the company\'s shares
Materials of the 2023 Annual General Meeting of Shareholders of Shanghai Mengke Pharmaceutical Co., Ltd.
Notice of Shanghai Mengke Pharmaceutical Co., Ltd. on holding the 2023 Annual General Meeting of Shareholders
Shanghai Mengke Pharmaceutical Co., Ltd. Investor Relations Event Schedule (March 27-28, 2024)
A special report by PricewaterhouseCoopers Zhongtian Certified Public Accountants on the storage and use of funds raised by Shanghai Mengke Pharmaceutical Co., Ltd. in 2023
Announcement of Resolutions of the Second Meeting of the Second Board of Directors of Shanghai Mengke Pharmaceutical Co., Ltd.
Announcement of Resolutions of the Second Meeting of the Second Board of Supervisors of Shanghai Mengke Pharmaceutical Co., Ltd.
Announcement of Shanghai Mengke Pharmaceutical Co., Ltd. on the extension of some fund-raising investment projects
China International Finance Corporation's inspection opinion on the extension of some fund-raising investment projects of Shanghai Mengke Pharmaceutical Co., Ltd.
No Data